Home > Healthcare > Biotechnology > Biotechnology R&D > 3D Bioprinting Market

3D Bioprinting Market Share

  • Report ID: GMI10305
  • Published Date: Jul 2024
  • Report Format: PDF

3D Bioprinting Market Share

The market is a fragmented, dynamic, and rapidly evolving market, characterized by significant technological advancements and competitive activities among leading players. Key market participants, including BICO Group AB, 3D Systems Corporation, Organovo Holdings Inc., and Merck KGaA, are driving innovation through advanced bioprinting technologies, expanded product offerings, and strategic collaborations. The market is influenced by trends such as the development of high-resolution bioprinting techniques, the expansion into emerging markets, and efforts to navigate complex regulatory environments.
 

While challenges such as high development costs and regulatory hurdles persist, there are substantial opportunities for growth in personalized medicine, advanced tissue engineering, and scalable bioprinting solutions. Companies that successfully leverage these opportunities and address market challenges are well-positioned for success in the competitive 3D bioprinting landscape.
 

3D Bioprinting Market Companies

Some of the eminent market participants operating in the 3D bioprinting industry include:

  • Advanced Solutions Life Sciences, LLC
  • Allevi, Inc.
  • Aspect Biosystems Ltd.
  • BICO Group AB
  • Brinter
  • CollPlant Biotechnologies Ltd.
  • CYFUSE BIOMEDICAL K.K.
  • ENVISIONTEC US LLC
  • Inventia Life Science Pty Ltd.
  • Merck KGaA
  • Organovo Holdings, Inc.
  • Poietis
  • regenHU
  • Rokit Healthcare, Inc.
  • 3D Systems Corporation
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global 3D bioprinting industry was valued at USD 1.6 billion in 2023 and is anticipated to register 16.7% CAGR between 2024 and 2032 due to the growing demand for organ transplants and tissue regeneration.

The bioinks segment in the market accounted for USD 694.8 million in 2023, propelled by the expanding range of clinical applications for bioprinted tissues and the ongoing advancements in bioink technology.

North America 3D bioprinting industry is forecasted to reach USD 3 billion by 2032, driven by strong R&D infrastructure and the development of cutting-edge bioprinting solutions.

Advanced Solutions Life Sciences, LLC, Allevi, Inc., Aspect Biosystems Ltd., BICO Group AB, Brinter, CollPlant Biotechnologies Ltd., CYFUSE BIOMEDICAL K.K., ENVISIONTEC US LLC, Inventia Life Science Pty Ltd., and Merck KGaA, among others.

3D Bioprinting Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 360
  • Countries covered: 23
  • Pages: 250
 Download Free Sample